openPR Logo
Press release

Physician Dispensed Cosmeceuticals Market Key Trends and Opportunity Analysis 2024

11-20-2017 10:38 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Physician Dispensed Cosmeceuticals Market Key Trends

According to TMR, the global physician dispensed cosmeceuticals market stood at US$11.2 bn in 2015. Rising at a CAGR of 10.6% between 2016 and 2024, the market is expected to reach US$27.6 bn by 2024.

With dermatologists manufacturing cosmeceuticals alongside running their skincare centers, the market is expected to gain momentum in the forthcoming years. However, consumer apprehensions related to potential side effects associated with the use of cosmeceuticals may stand in the way of the market’s growth. Besides this, the lack of awareness among customers regarding the revenue generating cosmeceuticals such as derma fillers and Botox is likely to create bottlenecks or the market in developing and under-developed countries. “Since the products offered in the market are highly sensitive to prevailing economic trends, financial downturns are also expected to have a negative impact on their sale,” said a lead analyst at TMR.

Read Report Overview @ https://www.transparencymarketresearch.com/physician-dispensed-cosmeceuticals-market.html

“Nevertheless, the rising demand for branded cosmeceuticals due to their safety and efficacy is expected to boost opportunities for the market in the near future,” he added. Furthermore, the knowledge about new skin conditions caused by exposure to pollution and climate changes will also boost sales of cosmeceuticals.

Among the products currently available in the market, the skincare products segment accounted for the leading market share in 2015. The increasing demand for cosmeceuticals across emerging economies and due to the rising geriatric population for treating various skin conditions will boost demand from this segment.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=565

Since the physician dispensed cosmeceuticals market offers a plethora of products, it is important for manufacturers to cater to the consumer preference to gain a strong footing in the market. Product differentiation has therefore become a preferred strategy among competitors to enhance the marketability of their products. Even local manufacturers are focusing on advanced cosmeceuticals with a myriad of benefits to elevate rivalry.

Regionally, North America has been exhibiting the most lucrative prospects for the sales of cosmeceuticals. As per TMR, the regional market stood at US$4.7 bn in 2015 and is expected to reach US$10.52 by the end of 2024. If these valuations hold true, the physician dispensed cosmeceuticals market in North America will exhibit a CAGR of 9.6% between 2016 and 2024. However, TMR forecasts opportunities for the market in Asia Pacific to increase at the fastest CAGR. The Asia Pacific physician dispensed cosmeceuticals market is therefore expected to surge at a CAGR of 12.3% during the forecast period.

Request Physician Dispensed Cosmeceuticals Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=565

The global physician dispensed cosmeceuticals market features the presence of prominent names from the skincare and cosmetic industry. The market is currently undergoing a paradigm shift with a large pool of skincare specialists, dermatologists, and trichologists emerging as entrepreneurs, states Transparency Market Research (TMR) in a new study. However, the top three companies, L'Oreal S.A., Valeant Pharmaceuticals Inc., and Allergan plc, held more than 56% of the market in 2015. Of these, L'Oreal S.A. accounted for a larger share of 28% in the same year.

Buy Full Physician Dispensed Cosmeceuticals Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=565<ype=S

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Physician Dispensed Cosmeceuticals Market Key Trends and Opportunity Analysis 2024 here

News-ID: 823940 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Physician

Physician Scheduling Systems Market 2026
This report focuses on the global Physician Scheduling Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Physician Scheduling Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Spok ABILITY Network Qgenda Intrigma OpenTempo Medevision Mediware Information Systems MDSYNCNET Jituzu Lightning Bolt Solutions McKesson Business Management Systems Market segment by Type, the product can be split into Software Services Market segment by Application, split
The Physician-Patient Relationship in Telemedicine
Telemedicine should be the modality used when considered to be in the best interest of the patient, for example when it can advance the possibility of treatment otherwise inaccessible, or where contact or physical presence in a clinical setting is not possible due to various constraints brought on by, geography or accessibility, illness or incapacitation, or being part of the medically underserved urban and rural populations. Is
Third Physician Group and First Orthopedic Practice Joins White Plains Hospital …
White Plains Hospital recently welcomed Westchester Orthopaedic Associates to its larger family. The practice of Louis McIntyre, M.D.; Michael Panio, M.D.; and Eric Zitzmann, M.D. is the third physician group to join the White Plains Hospital Physician Associates, a recently formed division of the hospital aligning local doctors with Hospital services. This new venture enables physicians and White Plains Hospital to share information, promote growth, better utilize resources
First Physician Group Joins White Plains Hospital Physician Associates
White Plains, NY – White Plains Hospital recently welcomed White Plains Surgical Specialists, formerly known as Weber, Weber and Yee, to the White Plains Hospital family. Additionally, as of August 1st, surgeon Kaare Weber joined the group. The practice becomes the first member of White Plains Hospital Physician Associates, a newly formed division of the Hospital, developed with the intent of aligning local practicing physicians with the Hospital. This new
Physician Assistant Programs 101 Guides Career Hopefuls On The Path To Becoming …
The health care industry is a growth sector of the American economy with thousands of jobs expected to be open in the coming years. It was once thought that health care was little more than doctors and nurses, but that has changed dramatically. New professions have grown up within the industry and physician assistant is one of them. It is anticipated that this one job category alone will experience growth
UCLA Physician Named Care Champion
The National Association For Continence (NAFC) awarded Shlomo Raz, MD, with the Rodney Appell Continence Care Champion Award at the Society for Urodynamics & Female Urology (SUFU) annual meeting in St. Petersburg, FL on February 26, 2010. The honor, presented by Eric Rovner, MD, professor of Urology at the Medical University of South Carolina and a member of NAFC’s Board of Directors, is sponsored by Pfizer Global Pharmaceuticals. Originally